SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001193125-18-015254
Filing Date
2018-01-22
Accepted
2018-01-22 06:43:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC14D9C d528098dsc14d9c.htm SC14D9C 8011
2 EX-99.A d528098dex99a.htm EX-99.(A) 20135
3 GRAPHIC g528098g0122121124523.jpg GRAPHIC 2737
4 GRAPHIC g528098g0122121124648.jpg GRAPHIC 2098
  Complete submission text file 0001193125-18-015254.txt   36724
Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filed by) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109
Business Address 400 DEXTER AVENUE NORTH, SUITE 1200 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Subject) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-88476 | Film No.: 18538690
SIC: 2836 Biological Products, (No Diagnostic Substances)